| Compound | Oligopeptide-10 |
|---|---|
| Category | Cosmetic antimicrobial peptide |
| Class | Other Injectables |
| Evidence tier | Minimal evidence |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
This entry covers Oligopeptide-10, a cosmetic antimicrobial peptide, graded "Minimal evidence" in this catalog's evidence system. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
A cosmetic ingredient peptide marketed for antimicrobial support in topical formulations.
Mechanism of Action
Reported to have antimicrobial activity in cosmetic-science testing.
Research and Evidence
Cosmetic-grade ingredient studies only.
Safety and Side Effects
Topical use acceptable in cosmetic contexts; no injectable data.
Frequently Asked Questions
What is the evidence tier of Oligopeptide-10?
Oligopeptide-10 is graded "Minimal evidence" on this site. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
Is Oligopeptide-10 an approved medicine?
No. Minimal evidence means the compound has not reached universal regulatory approval; the tier description above explains exactly what level of evidence exists.
Where can I read the primary studies for Oligopeptide-10?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — search for oligopeptide-10 studies. [source]
Evidence tier: Minimal evidence · Last reviewed: 2026-09-05 · Sources cited below.